Pooja Ghatalia

2.8k total citations · 1 hit paper
81 papers, 1.4k citations indexed

About

Pooja Ghatalia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Pooja Ghatalia has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 32 papers in Molecular Biology. Recurrent topics in Pooja Ghatalia's work include Renal cell carcinoma treatment (30 papers), Bladder and Urothelial Cancer Treatments (29 papers) and Urinary and Genital Oncology Studies (18 papers). Pooja Ghatalia is often cited by papers focused on Renal cell carcinoma treatment (30 papers), Bladder and Urothelial Cancer Treatments (29 papers) and Urinary and Genital Oncology Studies (18 papers). Pooja Ghatalia collaborates with scholars based in United States, United Kingdom and Canada. Pooja Ghatalia's co-authors include Robert G. Uzzo, Guru Sonpavde, Alexander Kutikov, Shreyas Joshi, Peter Makhov, Vladimir Kolenko, Elizabeth R. Plimack, Toni K. Choueiri, Daniel M. Geynisman and Youjin Je and has published in prestigious journals such as Cell, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Pooja Ghatalia

72 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies

2018 359 citations Pooja Ghatalia, Alexander Kutikov et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pooja Ghatalia United States	20	653	633	517	330	257	81	1.4k
Satoru Moriyama Japan	24	486 0.7×	929 1.5×	574 1.1×	245 0.7×	238 0.9×	82	1.7k
Jan Cosaert United States	17	644 1.0×	438 0.7×	1.1k 2.0×	336 1.0×	128 0.5×	43	1.5k
Yoshiyuki Suehara Japan	23	1.4k 2.2×	717 1.1×	863 1.7×	503 1.5×	269 1.0×	113	2.2k
Ingo Alldinger Germany	17	359 0.5×	354 0.6×	530 1.0×	204 0.6×	256 1.0×	38	1.0k
Andrew Dean Australia	17	694 1.1×	262 0.4×	1.1k 2.1×	267 0.8×	198 0.8×	104	1.6k
Zhixiang Zhou China	23	427 0.7×	300 0.5×	758 1.5×	203 0.6×	597 2.3×	117	1.4k
Tomasz Świtaj Poland	20	687 1.1×	291 0.5×	616 1.2×	154 0.5×	234 0.9×	109	1.4k
Marlies H.G. Langenberg Netherlands	15	417 0.6×	604 1.0×	749 1.4×	367 1.1×	79 0.3×	34	1.3k
Chiara Pierantoni Italy	16	366 0.6×	340 0.5×	809 1.6×	245 0.7×	155 0.6×	40	1.3k
Javier Puente Spain	18	639 1.0×	424 0.7×	786 1.5×	426 1.3×	320 1.2×	164	1.5k

Countries citing papers authored by Pooja Ghatalia

Since Specialization

Citations

This map shows the geographic impact of Pooja Ghatalia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pooja Ghatalia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pooja Ghatalia more than expected).

Fields of papers citing papers by Pooja Ghatalia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pooja Ghatalia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pooja Ghatalia. The network helps show where Pooja Ghatalia may publish in the future.

Co-authorship network of co-authors of Pooja Ghatalia

This figure shows the co-authorship network connecting the top 25 collaborators of Pooja Ghatalia. A scholar is included among the top collaborators of Pooja Ghatalia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pooja Ghatalia. Pooja Ghatalia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Joy & Pooja Ghatalia. (2025). A Practical Guide for the Management of Toxicities Associated with Belzutifan. European Urology Focus. 11(3). 408–410.

Ghatalia, Pooja, Eric A. Ross, Matthew R. Zibelman, et al.. (2025). A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2).. Journal of Clinical Oncology. 43(5_suppl). 815–815. 2 indexed citations

Kaur, Jasmeet, et al.. (2025). Comparison of Outcomes Between African American and European American Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer. 23(2). 102304–102304.

Anker, Jonathan F., et al.. (2024). Advancements in Urothelial Cancer Care: Optimizing Treatment for Your Patient. American Society of Clinical Oncology Educational Book. 44(3). e432054–e432054. 4 indexed citations

Agarwal, Neeraj, James Brugarolas, Pooja Ghatalia, et al.. (2024). Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma. Annals of Oncology. 35(12). 1148–1156. 6 indexed citations

Geynisman, Daniel M., Philip H. Abbosh, Eric A. Ross, et al.. (2024). Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1). Journal of Clinical Oncology. 43(9). 1113–1122. 9 indexed citations

Atkins, Michael B., Pooja Ghatalia, Jaime R. Merchan, et al.. (2024). Belzutifan in patients with advanced clear cell renal cellcarcinoma (ccRCC): Subgroup analysis of the phase 2 LITESPARK-013 study.. Journal of Clinical Oncology. 42(16_suppl). 4534–4534. 1 indexed citations

Brugarolas, James, Pooja Ghatalia, S. George, et al.. (2023). 1881O Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: Results of the randomized phase II LITESPARK-013 study. Annals of Oncology. 34. S1011–S1011. 4 indexed citations

Handorf, Elizabeth A., Pooja Ghatalia, Benjamin Miron, et al.. (2023). Survival outcomes in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy stratified by number of cycles.. Journal of Clinical Oncology. 41(16_suppl). 4586–4586.

10.

Armstrong, Andrew J., Noel W. Clarke, Giuseppe Procopio, et al.. (2023). Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial. European Urology Oncology. 7(2). 292–296. 1 indexed citations

11.

Cotta, Brittney, Toni K. Choueiri, Marcin Cieślik, et al.. (2023). Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma. European Urology. 84(2). 166–175. 39 indexed citations

12.

Ghatalia, Pooja, Jasmeet Kaur, & Guru Sonpavde. (2023). Muscle invasive bladder cancer: where is the field headed?. Expert Opinion on Biological Therapy. 23(9). 913–927. 2 indexed citations

13.

Bilušić, Marijo, Renee N. Donahue, Susan Wróblewski, et al.. (2022). A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate Cancer and Prostatic Diseases. 25(4). 735–740. 17 indexed citations

14.

Ghatalia, Pooja, et al.. (2022). Immune Gene Signature Expression Differs between African American and Caucasian Patients with Renal Cell Carcinoma. 6(2). 109–114. 2 indexed citations

15.

Nam, Hyeyoung, Anirban Kundu, Garrett J. Brinkley, et al.. (2020). PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. Matrix Biology. 89. 43–58. 20 indexed citations

16.

Nicolas, Émmanuelle, Ilya G. Serebriiskii, Pooja Ghatalia, et al.. (2019). Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma. Molecular Genetics & Genomic Medicine. 7(3). e556–e556. 9 indexed citations

17.

Ghatalia, Pooja & Elizabeth R. Plimack. (2019). Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer. Nature Medicine. 25(11). 1650–1651. 6 indexed citations

18.

Nam, Hyeyoung, Darshan S. Chandrashekar, Anirban Kundu, et al.. (2018). Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Molecular Cancer Research. 17(1). 84–96. 34 indexed citations

19.

Ghatalia, Pooja, Gregory R. Pond, Arnoud J. Templeton, & Guru Sonpavde. (2017). Effect of Single-agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-resistant Prostate Cancer: Pooled Analysis of Prospective Studies. Clinical Genitourinary Cancer. 16(2). e277–e287. 4 indexed citations

20.

Ghatalia, Pooja, Joanne C. Porter, Danielle Wroblewski, & J. Andrew Carlson. (2013). Primary cutaneous marginal zone lymphoma associated with juxta‐articular fibrotic nodules in a teenager. Journal of Cutaneous Pathology. 40(5). 477–484. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact